Spotlight

UCL cancer immunotherapy company, Autolus, launches with £30m investment

A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.

Find out more



follow us on twitter


Entrepreneurial Finance

Publication date: May 25, 2012 04:54 PM

Start: Jun 28, 2012 09:30 AM
End: Jul 04, 2012 05:00 PM

[image reference is broken]

The Entrepreneurial Finance programme is designed for anybody who is intending or even just interested in becoming an entrepreneur by setting up their own business.

It would also be of value to individuals who are interested in becoming investors in another group’s entrepreneurial endeavour.